NCT05616702

Brief Summary

Low back pain is common MSK disease with prevalence of 60 to 70 percent. Patients with low back discomfort are typically treated conservatively by physical therapists. Progressive muscles relaxation technique has been shown in several studies to reduce chronic back pain and increase flexibility. pressure biofeedback therapy works on Intra abdominal pressure.it helps to alleviate compression on lumbar spine and support the adjacent lumbar spine.The aim of this randomized controlled trial is to determine the effectiveness of pressure biofeedback training (Pr.BFB) in combination with progressive muscles relaxation technique (PMR) \& progressive muscles relaxation training alone on pain, disability, ROM \& endurance of muscles among nonspecific chronic low back pain patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2022

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

October 29, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 15, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 27, 2023

Completed
Last Updated

July 10, 2023

Status Verified

July 1, 2023

Enrollment Period

1 year

First QC Date

October 29, 2022

Last Update Submit

July 6, 2023

Conditions

Keywords

Pressure Biofeedback therapyprogressive muscles relaxation techniquechronic non-specific low back painchronic low back painnon specific back pain

Outcome Measures

Primary Outcomes (2)

  • Numeric Pain Rating Scale (change is being assessed)

    On a scale of 0 to 10, "Please indicate the intensity of current, best, and worst pain levels over the past 24 hours on a scale of 0 (no pain) to 10 (worst pain imaginable)"

    Baseline and 6 weeks

  • Roland-Morris Low Back Pain and Disability Questionnaire (change is being assessed)

    A standard tool called the "Roland-Morris Disability Questionnaire" consists of 24 items about a person's disabilities and pain perceptions The patient is told to draw a mark beside each element that corresponds to him or her. Sum of marked items will determine a patient's score. The scoring ranges from 0 - 24. (No to extreme disability).

    Baseline and 6 weeks

Secondary Outcomes (3)

  • Endurance test (change is being assessed) (mmHg)

    Baseline and 6 weeks

  • Endurance test (change is being assessed) (hold time in seconds)

    Baseline and 6 weeks

  • Lumbar Range of Motion (cm) (change is being assessed)

    Baseline and 6 weeks

Study Arms (2)

Pressure Biofeedback Therapy + Progressive Muscle Relaxation Technique + Thermotherapy.

EXPERIMENTAL

This study ARM will receive following therapies 1. Pressure Biofeedback Therapy 2. Progressive Muscles Relaxation Technique 3. Thermotherapy

Other: Pressure Biofeedback Therapy + Progressive Muscles Relaxation + thermotherapy

Progressive Muscle Relaxation Technique + Thermotherapy

ACTIVE COMPARATOR

This study ARM will receive following therapies 1. Progressive Muscles Relaxation Technique 2. Thermotherapy

Other: Progressive Muscles Relaxation + thermotherapy

Interventions

Pressure Biofeedback Therapy * prone position, abdominal drawing in for 10 sec. (PBU inflated to 70 mmHg) * Supine position with flexed knees, abdominal drawing in for 10 sec. (PBU inflated to 40 mmHg) * Progress to leg loading in supine abdominal drawing in for 10 sec. (PBU inflated to 40 mmHg) Exercising dosage: * Duration: 15 mins * Frequency: 3 sessions/ week * Repetitions: 3 sets of 15 reps Progressive Muscles Relaxation Technique * Tense =\> five seconds and, * release =\> ten seconds (Each group of muscle) * 2 circuits daily Exercising dosage: * Duration: 15 mins * Frequency: weekly 3 sessions; for 6 weeks * Repetitions: 2 reps (cycles) Thermotherapy at lumbar region via electrical heating pad Duration: 15 mins

Pressure Biofeedback Therapy + Progressive Muscle Relaxation Technique + Thermotherapy.

Progressive Muscles Relaxation Technique * Tense =\> five seconds and, * release =\> ten seconds (Each group of muscle) * 2 circuits daily Exercising dosage: * Duration: 15 mins * Frequency: weekly 3 sessions; for 6 weeks * Repetitions: 2 reps (cycles) Thermotherapy at lumbar region via electrical heating pad Duration: 15 mins

Progressive Muscle Relaxation Technique + Thermotherapy

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed and referred patients with non-specific low back pain for more than 3 months
  • to 50 years
  • Both genders

You may not qualify if:

  • Any surgical history of lumbar spine
  • Infections of the spine, malignancy
  • Disc protrusion
  • History of spinal fractures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dow Institute of Physical Medicine and Rehabilitation, DUHS.

Karachi, Sindh, 74200, Pakistan

RECRUITING

MeSH Terms

Conditions

Low Back PainChronic PainBack Pain

Interventions

Hyperthermia, Induced

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Farhan I Khan, Ph.D, MBA, MSc.PT, DPT

    Dow University of Health Sciences

    STUDY DIRECTOR

Central Study Contacts

Shaiaza Masooma, DPT

CONTACT

Farhan I Khan, Ph.D, MBA, MSc.PT, DPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 29, 2022

First Posted

November 15, 2022

Study Start

October 15, 2022

Primary Completion

October 16, 2023

Study Completion

November 27, 2023

Last Updated

July 10, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations